African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 11, November 2025 | pp. 936–942

DOI: 10.46882/AJIDR/148897

Article Type: Research Article

Title: Antimicrobial susceptibility and beta-lactamase gene profiles of Stenotrophomonas maltophilia isolated from hospitalized immunocompromised patients

Names of Authors: Youssef Mansour¹*, Katrin Weber², Mei-Ling Chen³

Authors’ Affiliations: ¹Department of Clinical Pathology, Cairo University, Cairo, Egypt. ²Department of Medical Microbiology, Heidelberg University, Heidelberg, Germany. ³Department of Laboratory Medicine, National Taiwan University, Taipei, Taiwan.

Abstract: Stenotrophomonas maltophilia is an emerging multidrug-resistant non-fermenting Gram-negative bacillus causing severe nosocomial pneumonia and bacteremia in debilitated hosts. We evaluated antimicrobial susceptibility patterns and sul1 and dfrA resistance determinants among clinical S. maltophilia isolates. A total of 110 non-duplicate isolates from respiratory and bloodstream specimens underwent broth microdilution testing and polymerase chain reaction assays. Trimethoprim-sulfamethoxazole and levofloxacin demonstrated 88.2 percent and 84.5 percent susceptibility, respectively, whereas intrinsic resistance to carbapenems and aminoglycosides was universal. Restricting unnecessary carbapenem exposure is critical to prevent selection pressure.

Keywords: Stenotrophomonas maltophilia, Nosocomial infection, Multidrug resistance, Trimethoprim-sulfamethoxazole, Antimicrobial stewardship

Citation: Mansour Y, Weber K, Chen M (2025). Antimicrobial susceptibility and beta-lactamase gene profiles of Stenotrophomonas maltophilia isolated from hospitalized immunocompromised patients. African Journal of Infectious Diseases Research, 12(11): 936–942. DOI: 10.46882/AJIDR/148897

Manuscript Timeline: Received: October 01, 2025; Revised: November 01, 2025; Accepted: November 14, 2025; Published: November 21, 2025